Back to
News releases
Access all of the press releases and statements related to the work of the Vaccine Alliance
Access all of the press releases and statements related to the work of the Vaccine Alliance
The Ministry of Health announced today the introduction of the one-dose human papillomavirus (HPV) vaccine for girls aged nine years old into the national immunization schedule, available free of charge, to prevent cervical cancer in Cambodia.
Africa Centres for Disease Control and Prevention (Africa CDC) and Gavi, the Vaccine Alliance hosted by the Kingdom of Morocco opened the First Manufacturers Marketplace for Vaccine Manufacturing African Union Member States.
The Government of Bangladesh launches nationwide human papillomavirus (HPV) vaccination campaign
The Government of Bangladesh, supported by UNICEF, the Vaccine Alliance (Gavi), and WHO, has launched a ground-breaking Human Papillomavirus (HPV) vaccination campaign.
RBM Partnership to End Malaria welcomes WHO’s recommendation of world’s second malaria vaccine
Global malaria community calls for increased investment in development and scale-up of malaria innovations following R21 vaccine announcement – but RBM Partnership warns “it’s not the only solution”.
Basic childhood immunisation rebounded in 2022, as lower-income countries committed historic levels of domestic funding to immunisation programmes.
New funding boosts efforts to vaccinate “zero-dose” children in the Democratic Republic of the Congo
Efforts to vaccinate “zero-dose” children in the Democratic Republic of the Congo (DRC) will be accelerated thanks to new funding from Gavi, the Vaccine Alliance’s Equity Accelerator Fund (EAF).
Lower-income countries supported by the Alliance are on the road to recovery, with DTP3 vaccine coverage going up by 3 percentage points.
Through a memorandum of understanding (MoU), the three organizations will work together to coordinate and facilitate the exchange of information, experience and knowledge concerning audit and advisory activities.
Twelve countries across different regions in Africa are set to receive 18 million doses of the first-ever malaria vaccine over the next two years.
Gavi’s Board approved new investments in six-in-one (hexavalent) vaccine and approved a long list of potential new vaccines for consideration for inclusion in future Gavi programmes at its Board Meeting, which concluded today
David Marlow to Become Interim Chief Executive Officer of Gavi
The Gavi Board decided today to appoint David Marlow, currently Gavi`s Chief Operating Officer, to the position of Interim Chief Executive Officer, effective 3 August 2023.
The Global Vaccine Impact Conference closed today, as the Vaccine Alliance marked more than 1 billion children vaccinated through its programmes.